-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732.O2.6 732. Clinical Allogeneic Transplantation: Results II

Clinical Allogeneic Transplantation: Results Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 5, 2015: 4:00 PM-5:30 PM
W304, Level 3 (Orange County Convention Center)
Moderators:
Nelli Bejanyan, MD, University of Minnesota and Jurgen Finke, M.D., University of Freiburg

Disclosures:
Finke: Neovii, Novartis: Consultancy , Research Funding , Speakers Bureau ; Riemser: Research Funding , Speakers Bureau ; Medac: Research Funding .
4:00 PM

Margaret M. Showel, MD1*, Ephraim J. Fuchs1, Ravi Varadhan, PhD2*, Mark J. Levis, MD, PhD3 and Richard J. Jones Sr., MD4

1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
2Johns Hopkins University, Baltimore, MD
3Johns Hopkins University School of Medicine, Baltimore, MD
4Sidney Kimmel Comprehensive Cancer Cancer, Baltimore, MD

4:15 PM

Sameh Gaballa, MD1, Isabell Ge2*, Riad O. El Fakih, MD,1*, Jonathan E. Brammer, MD1, Sa A. Wang, MD3*, Dean A. Lee, MD, PhD4, Demetrios Petropoulos, MD4, Kai Cao, MS, MD5*, Gabriela Rondon, MD1, Julianne Chen1*, Aimee E Hammerstrom, PharmD, BCOP1*, Gheath Al-Atrash, MD, PhD1*, Martin Korbling, MD1*, Betul Oran, MD1, Partow Kebriaei, MD1, Sairah Ahmed, MD1, Nina Shah, MD1, Katayoun Rezvani, MD PhD1, David Marin, MD1*, Qaiser Bashir, MD1, Amin M. Alousi, MD1, Yago Nieto, MD, PhD1, Muzaffar H. Qazilbash, MD1, Chitra M. Hosing, MD1, Uday R. Popat, MD1, Elizabeth J. Shpall, MD1, Issa F. Khouri1, Richard E. Champlin, MD1 and Stefan O. Ciurea, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Medical Faculty of Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Pediatric Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX
5Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

4:30 PM

Simona Pagliuca1,2*, Régis Peffault de Latour, MD1*, Franco Locatelli, Prof, MD, PhD3, Jean-Hugues Dalle, PhD, MD4, Kim Vettenranta, MD, PD5, Miguel Angel Diaz, MD, PhD6*, Or Reuven7*, Cristina Diaz de Heredia, MD8*, Arnon Nagler, MD, MSc9, Ardeshir Ghavamzadeh, Professor10, Sabina Sufliarska, MD11*, Sarah Lawson12*, Chantal Kenzey, CRA13*, Vanderson Rocha, MD, PhD14,15, Carlo Dufour, MD16, Eliane Gluckman, MD13, Jakob Passweg17 and Annalisa Ruggeri, MD, PhD18,19*

1Hôpital Saint-Louis – Assistance Publique-Hôpitaux de Paris, Paris, France
2University of Naples Federico II, Naples, Italy
3Oncoematologia Pediatrica, Fondazione IRCCS Policlinico S. Matteo, Università di Pavia, Pavia, Italy
4Pediatric hematology immunology, Robert Debre Hospital, Paris, France
5University of Helsinki Children's Hosp., Helsinki, Finland
6Niño Jesus Children`s Hospital, Madrid, Spain
7Hadassah University Hospital, Jerusalem, Israel
8Servicio de Hematologia y Oncologia Pediátrica, Hospital Vall d'Hebron, Barcelona, Spain
9Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel
10Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
11Bone Marrow Transplantation Unit, Comenius University Children's Hospital, Bratislava, Slovakia
12Department of Haematology, Birmingham Childrens Hospital, Birmingham, United Kingdom
13Eurocord International Registry, Paris, France
14Churchill Hospital, Oxford University, Oxford, United Kingdom
15Eurocord - Monacord, Hôpital Saint Louis, Paris, France
16Istituto Giannina Gaslini, Genoa, Italy
17Hopitaux Universitaires de Geneve, Geneve, Switzerland
18Eurocord, Hôpital Saint Louis APHP, University Paris-Diderot, Paris, France
19Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France

4:45 PM

Sachiko Seo, MD, Ph.D.1, Junya Kanda2, Yoshiko Atsuta, MD, Ph.D3,4*, Naoyuki Uchida5, Kazuteru Ohashi, MD, FACP6, Takahiro Fukuda, MD7*, Satoshi Takahashi, M.D., Ph.D.8, Yukiyasu Ozawa, MD9*, Makoto Onizuka, MD, PhD10, Minoko Takanashi, MD, Ph.D11*, Nobuhiro Tsukada, MD, PhD12, Shunichi Kato, MD, PhD13, Fumihiko Kimura, MD14, Yoshinobu Kanda, MD, PhD2 and Koichi Miyamura, MD, PhD15

1Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan
2Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
3Japanese Data Center for Haematopoietic Cell Transplantation, Nagoya, Japan
4Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan
5Department of Hematology, Toranomon Hospital, Tokyo, Japan
6Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
7Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
8Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Sciece, Univ. of Tokyo, Tokyo, Japan
9Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
10Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
11Blood Service Headquarters, Japanese Red Cross, Tokyo, Japan
12Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
13Tokai University School of Medicine, Isehara, Japan
14Division of Hematology, National Defense Medical College, Tokorozawa, Japan
15Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

5:00 PM

Frederic Baron, MD, PhD1, Ruggeri Annalisa, MD2*, Eric Beohou3*, Myriam Labopin, MD4*, Guillermo Sanz, MD, PhD5, Noel Milpied6, Mauricette Michallet, MD, PhD7, Andrea Bacigalupo, MD8, Gerard Socie9, Didier Blaise10, Jorge Sierra11, Jan Cornelissen, MD, PhD12, Mohamad Mohty, MD, PhD13, Christoph Schmid, MD14, Sebastian Giebel, MD, PhD15*, Norbert Claude Gorin, Pr, MD, PhD16, Jordi Esteve, MD, PhD17, Fabio Ciceri, MD18*, Bipin N. Savani, MD19, Eliane Gluckman, MD20 and Arnon Nagler, MD, MSc4,21

1Hematology and GIGA Research, CHU Sart Tilman, Liege, Belgium
2Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, Paris, France
3EBMT Paris Office, Hospital Saint Antoine, Paris, France
4EBMT, Acute Leukemia Working Party, Paris, France
5Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain
6Service d’Hematologie Clinique et Therapie Cellulaire, CHU Haut-Lévêque, Bordeaux, France
7Department of Hematology, Centre Hospitalier Lyon-Sud, Lyon, France
8Ospedale S. Martino, Genova, Italy
9St-Louis Hospital, Paris, France
10Department of Hematology, Institut Paoli Calmettes, Marseille, France
11Department of Hematology, Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona, Barcelona, Spain
12Department of Hematology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, Netherlands
13Hematology Department, Saint-Antoine Hospital, AP-HP, Universite Pierre et Marie Curie, Paris, France
14Ludwig-Maximilians-University of Munich, Germany, Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany
15Dept. of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
16Hematology-cell therapy and EBMT, Hopital Saint-Antoine and Universite Pierre et Marie Curie UPMC, Paris, France
17Hematology, Hospital Clínic, IDIBAPS, Barcelona, Spain
18Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
19Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
20Eurocord International Registry, Paris, France
21Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel

5:15 PM

Mei Guo1*, Chang-Lin Yu2*, Zheng Dong3*, Kaixun Hu1*, Qiyun SUN1*, Jianhui Qiao1*, Wanjun SUN4*, Hongli Zuo1*, Yajing Huang1*, Junxiao Qiao5*, Bo CAI1*, Zhiqing LIU1*, Bo Yao1*, Tieqiang LIU1*, Hongxia Zhao4*, Xuedong SUN1*, Xuliang Shen, MD6*, Xinrong Zhan7*, Juan WANG8*, Jianyong Li, MD, PhD9, Liangping HU10*, Qianqian Zhou11* and Huisheng Ai, MD12*

1Affiliated Hospital of Academy of Military Medical Sciences, BEIJING, China
2Affiliated Hospital of Academy of Military Medical Sciences, beijing, China
3Affiliated Hospital of Academy of Military Medical Sciences, beijig, China
4Second Artillery General Hospital, BEIJING, China
5Second Artillery General Hospital, BEIJNG, China
6Heping Hospital of Changzhi Medical College, Changzhi, China
7Central Hospital of Xinxiang City, XINXIANG, China
8Central Hospital of Cangzhou City, CANGZHOU, China
9Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
10Statistics Department of Academy of Military Medical Sciences, BEIJING, China
11Beijing Institute of Transfusion Medicine, BEIJING, China
12Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, BEIJING, China

*signifies non-member of ASH